Anzeige
Mehr »
Login
Dienstag, 24.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000?% RENDITE!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PBYQ | ISIN: US29350E1047 | Ticker-Symbol: 2Q5
Frankfurt
23.12.24
15:07 Uhr
1,592 Euro
+0,148
+10,25 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RENOVARO INC Chart 1 Jahr
5-Tage-Chart
RENOVARO INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0441,11823.12.

Aktuelle News zur RENOVARO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoRenovaro's subsidiary receives approval of Lumina project by the Eurostars funding program2
MoRenovaro Inc: RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program166LUMINA is an Advanced Minimal Residual Disease Detection Platform for Lung Cancer Harnessing the Power of Multi-omics Biomarkers and AI LOS ANGELES and AMSTERDAM, Dec. 23, 2024 (GLOBE NEWSWIRE)...
► Artikel lesen
FrRenovaro regains Nasdaq compliance with bid price rule5
FrRenovaro Inc: Renovaro Regains Compliance with NASDAQ Listing Requirement266LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced that it has received...
► Artikel lesen
FrRenovaro teams up with Nebul for AI-driven cancer detection2
FrRenovaro Inc: Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection289Renovaro will Establish the GEDi CUBE Next Generation Nvidia Blackwell Cluster with Nebul's certified AI Healthcare Cloud solutions LOS ANGELES, Dec. 20, 2024) a leading AI cloud infrastructure...
► Artikel lesen
RENOVARO Aktie jetzt für 0€ handeln
21.11.RENOVARO INC. - 8-K, Current Report1
08.11.Renovaro Inc. revises CFO compensation package1
08.11.Renovaro Inc. passt Vergütungspaket des CFO an3
08.11.RENOVARO INC. - 8-K, Current Report-
04.11.Renovaro Inc: Renovaro Issues Shareholder Letter and Provides Corporate Update289LOS ANGELES, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today issued a letter to shareholders...
► Artikel lesen
28.10.RENOVARO INC. - 10-K/A, Annual Report1
17.10.Renovaro Inc: RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing407AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) - RenovaroCube, a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies, is excited to announce the presentation...
► Artikel lesen
16.10.Renovaro Inc appoints new CEO, revamps board4
16.10.Renovaro Inc: Renovaro Announces Strategic Restructuring and Leadership Transition369Supermajority of Shareholders Support Appointment of New CEO and the Replacement of Entire Board of Directors with Full Five-Member SlateRealignment of Resources to Optimize and Commercialize RenovaroCube...
► Artikel lesen
16.10.RENOVARO INC. - 8-K, Current Report3
10.10.RENOVARO INC. - 10-K, Annual Report4
01.10.RENOVARO INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4053
19.09.Renovaro Inc: PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics382Strategic partnership aims to further develop Cube's award-winning AI guided platform for Software as a Service (SaaS) for the private sector and large healthcare systems and diagnostic to support clinicians...
► Artikel lesen
17.09.Renovaro faces Nasdaq delisting over share price woes5
Seite:  Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,9